Arch Size Study for Anatomical Variations
Launched by IRCCS SAN RAFFAELE · Jan 23, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Arch Size Study for Anatomical Variations is a clinical trial that aims to better understand the different shapes and sizes of the aortic arch, which is a part of the heart's major blood vessel system. Specifically, the study is looking at a condition known as CILCA, where the innominate artery and left carotid artery start from the same point. This condition, once thought to be harmless, may actually be linked to more serious heart issues. Researchers will examine CT scans from patients across five major cardiovascular centers in Europe, comparing those with aortic aneurysms (bulges in the aorta) to those without.
Anyone who has had a CT scan of their aortic arch at one of the participating centers can potentially join this study, regardless of their age or gender. There are no specific exclusions, so anyone with the right scan can participate. If you take part in this study, you can expect your CT scan data to be reviewed and analyzed to help researchers learn more about how variations in the aortic arch might affect heart health. This information could be important for improving diagnosis and treatment in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients with aortic arch CT scan at investigating centers
- Exclusion Criteria:
- • none
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported